Pathway,Pathway count
Fanconi Anemia Pathway,104
Resolution of D-loop Structures through Holliday Junction Intermediates,104
Major pathway of rRNA processing in the nucleolus and cytosol,98
SRP-dependent cotranslational protein targeting to membrane,97
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),97
Formation of a pool of free 40S subunits,97
Ribosomal scanning and start codon recognition,97
"Formation of the ternary complex, and subsequently, the 43S complex",97
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),97
L13a-mediated translational silencing of Ceruloplasmin expression,97
GTP hydrolysis and joining of the 60S ribosomal subunit,94
Translation initiation complex formation,82
Respiratory electron transport,77
phosalacine biosynthesis,59
phosphinothricin tripeptide biosynthesis,59
CMP-legionaminate biosynthesis I,57
cytidine-5'-diphosphate-glycerol biosynthesis,54
daunorubicin biosynthesis,53
2-deoxy-D-ribose degradation II,52
tryptoquialanine biosynthesis,52
mithramycin biosynthesis,51
erinacine biosynthesis,51
representative whole plasma arachidonate-derived icosanoids II,50
aurofusarin biosynthesis,50
cis-geranyl-CoA degradation,50
zwittermicin A biosynthesis,50
arachidonate metabolites biosynthesis,50
aclacinomycin biosynthesis,50
cholesterol degradation to androstenedione II (cholesterol dehydrogenase),50
autoinducer CAI-1 biosynthesis,50
septacidin biosynthesis,50
sphingofungin B-D biosynthesis,50
sitosterol degradation to androstenedione,50
bikaverin biosynthesis,50
6-methylpretetramide biosynthesis,50
representative whole plasma arachidonate-derived icosanoids I,50
6-gingerol analog biosynthesis (engineered),50
mycolate biosynthesis,50
8-O-methylfusarubin biosynthesis,50
"docosahexaenoate biosynthesis III (6-desaturase, mammals)",50
salinosporamide A biosynthesis,50
androstenedione degradation I (aerobic),50
cholesterol degradation to androstenedione I (cholesterol oxidase),50
"(4Z,7Z,10Z,13Z,16Z)-docosapentaenoate biosynthesis (6-desaturase)",50
guadinomine B biosynthesis,50
(2R)-methoxymalonyl-[acp] biosynthesis,50
prodigiosin biosynthesis,50
androstenedione degradation II (anaerobic),50
mupirocin biosynthesis,50
antimycin biosynthesis,50
stearate biosynthesis I (animals),49
hygromycin B biosynthesis,49
cutin biosynthesis,49
sporopollenin precursors biosynthesis,49
suberin monomers biosynthesis,49
phenolphthiocerol biosynthesis,48
apicidin biosynthesis,48
phthiocerol biosynthesis,48
alpha-solanine/alpha-chaconine biosynthesis,48
dehydrophos biosynthesis,48
"24-epi-campesterol, fucosterol, and clionasterol biosynthesis (diatoms)",47
(-)-dehydrodiconiferyl alcohol degradation,47
"dTDP-alpha-D-olivose, dTDP-alpha-D-oliose and dTDP-alpha-D-mycarose biosynthesis",47
fusicoccin A biosynthesis,47
dTDP-4-O-demethyl-beta-L-noviose biosynthesis,47
ephedrine biosynthesis,47
pyrimidine deoxyribonucleotides de novo biosynthesis IV,47
dTDP-beta-L-mycarose biosynthesis,47
terrequinone A biosynthesis,47
3-hydroxy-L-homotyrosine biosynthesis,47
mannojirimycin biosynthesis,47
dTDP-beta-L-megosamine biosynthesis,47
patulin biosynthesis,47
pyrimidine deoxyribonucleotides de novo biosynthesis I,47
ecdysteroid metabolism (arthropods),47
dTDP-beta-L-4-epi-vancosamine biosynthesis,47
pyrimidine deoxyribonucleotides biosynthesis from CTP,47
pyrimidine deoxyribonucleotides de novo biosynthesis III,47
ATP biosynthesis,46
"bile acid biosynthesis, neutral pathway",46
phenylethanol biosynthesis,46
UDP-N-acetyl-beta-L-quinovosamine biosynthesis,46
heme d1 biosynthesis,46
methyl tert-butyl ether degradation,46
bisphenol A degradation,46
(Z)-phenylmethanethial S-oxide biosynthesis,46
GDP-6-deoxy-D-altro-heptose biosynthesis,46
myxochelin A and B biosynthesis,46
S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation III,46
butanol and isobutanol biosynthesis (engineered),46
2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA,46
UDP-N-acetyl-D-galactosamine biosynthesis III,46
pyruvate fermentation to butanol I,46
"9-cis, 11-trans-octadecadienoyl-CoA degradation (isomerase-dependent, yeast)",46
11-cis-3-hydroxyretinal biosynthesis,46
D-galactose degradation IV,46
"1,2-propanediol biosynthesis from lactate (engineered)",46
(S)-camphor degradation,46
leporin B biosynthesis,46
adenosine deoxyribonucleotides de novo biosynthesis I,46
abscisic acid degradation to phaseic acid,46
meso-butanediol biosynthesis II,46
L-glucose degradation,46
"3-amino-4,7-dihydroxy-coumarin biosynthesis",46
phytosterol biosynthesis (plants),46
L-isoleucine biosynthesis II,46
glycolysis II (from fructose 6-phosphate),46
dihydroconiferyl alcohol biosynthesis,46
kanosamine biosynthesis I,46
GDP-6-deoxy-D-manno-heptose biosynthesis,46
pyrethrin I biosynthesis,46
epoxypseudoisoeugenol-2-methylbutanoate biosynthesis,46
propane degradation II,46
reductive TCA cycle II,46
sulfolactate degradation II,46
adenosine deoxyribonucleotides de novo biosynthesis II,46
guanosine deoxyribonucleotides de novo biosynthesis II,46
dTDP-beta-L-digitoxose biosynthesis,46
"oryzalexin A, B, and C biosynthesis",46
4-ethylphenol degradation (anaerobic),46
L-galactose degradation,46
gluconeogenesis II (Methanobacterium thermoautotrophicum),46
L-ascorbate degradation IV,46
t-anethole biosynthesis,46
the visual cycle (insects),46
superpathway of nicotine biosynthesis,46
quinoxaline-2-carboxylate biosynthesis,46
tRNA splicing II,46
glycine betaine biosynthesis II (Gram-positive bacteria),46
CDP-6-deoxy-D-gulose biosynthesis,46
cinchona alkaloids biosynthesis,46
sulfolactate degradation III,46
dTDP-L-daunosamine biosynthesis,46
L-homomethionine biosynthesis,46
p-cymene degradation to p-cumate,46
limonene degradation IV (anaerobic),46
erythritol degradation II,46
L-canavanine degradation II,46
"10-trans-heptadecenoyl-CoA degradation (reductase-dependent, yeast)",46
2-keto-L-gulonate biosynthesis,46
UDP-beta-L-rhamnose biosynthesis,46
guanosine deoxyribonucleotides de novo biosynthesis I,46
validamycin biosynthesis,46
CDP-ascarylose biosynthesis,46
"pterocarpan phytoalexins modification (maackiain, medicarpin, pisatin, phaseollin)",46
myo-inositol degradation II,46
testosterone degradation (anaerobic),46
3-sulfopropanediol degradation I,46
nicotine biosynthesis,46
pyruvate fermentation to butanol II (engineered),46
3-sulfopropanediol degradation II,46
tetramethylpyrazine degradation,46
UDP-N-acetyl-alpha-D-fucosamine biosynthesis,46
pinitol biosynthesis I,46
dimethylsulfoniopropanoate biosynthesis III (algae and phytoplankton),46
6-diazo-5-oxo-L-norleucine biosynthesis,46
juglone degradation,46
4-oxopentanoate degradation,46
isethionate degradation,46
detoxification of reactive carbonyls in chloroplasts,46
cyathin biosynthesis,46
"1,3-propanediol biosynthesis (engineered)",46
fatty acid beta-oxidation VII (yeast peroxisome),46
L-tryptophan degradation V (side chain pathway),46
arabidopyrone biosynthesis,46
dTDP-beta-L-olivose biosynthesis,46
meso-butanediol biosynthesis I,46
"10-trans-heptadecenoyl-CoA degradation (MFE-dependent, yeast)",46
propane degradation I,46
10-cis-heptadecenoyl-CoA degradation (yeast),46
jasmonic acid biosynthesis,46
ecdysone and 20-hydroxyecdysone biosynthesis,46
pyruvate fermentation to hexanol (engineered),46
L-threitol degradation,46
Insulin receptor recycling,44
Transferrin endocytosis and recycling,39
lipoprotein posttranslational modification (Gram-negative bacteria),38
mTORC1-mediated signalling,35
Amino acids regulate mTORC1,33
ROS and RNS production in phagocytes,33
Complex I biogenesis,28
Post-translational protein phosphorylation,27
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),27
Protein hydroxylation,27
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,26
Integrin cell surface interactions,25
Neutrophil degranulation,25
Role of phospholipids in phagocytosis,25
Termination of translesion DNA synthesis,24
Dual incision in TC-NER,24
Removal of the Flap Intermediate,24
Polymerase switching,24
Processive synthesis on the lagging strand,24
ECM proteoglycans,24
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",23
PIP3 activates AKT signaling,23
Cell surface interactions at the vascular wall,22
Activation of the pre-replicative complex,21
Inhibition of replication initiation of damaged DNA by RB1/E2F1,21
Recognition of DNA damage by PCNA-containing replication complex,21
PCNA-Dependent Long Patch Base Excision Repair,21
DNA replication initiation,21
Degradation of the extracellular matrix,20
RAF/MAP kinase cascade,20
Generation of second messenger molecules,19
Regulation of expression of SLITs and ROBOs,19
Gap-filling DNA repair synthesis and ligation in TC-NER,18
Gap-filling DNA repair synthesis and ligation in GG-NER,18
Dual Incision in GG-NER,18
Platelet degranulation,18
Downstream TCR signaling,18
A tetrasaccharide linker sequence is required for GAG synthesis,18
Glycerophospholipid catabolism,18
Adherens junctions interactions,17
Platelet sensitization by LDL,17
Translesion synthesis by POLK,16
Small interfering RNA (siRNA) biogenesis,16
Translocation of ZAP-70 to Immunological synapse,16
Cargo recognition for clathrin-mediated endocytosis,16
Receptor-type tyrosine-protein phosphatases,16
"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",16
Co-inhibition by PD-1,16
Regulation of actin dynamics for phagocytic cup formation,16
FCGR activation,16
Phosphorylation of CD3 and TCR zeta chains,16
Clathrin-mediated endocytosis,16
Translesion synthesis by REV1,15
Translesion synthesis by POLI,15
Other interleukin signaling,15
Classical antibody-mediated complement activation,15
Post-translational modification: synthesis of GPI-anchored proteins,15
FCERI mediated NF-kB activation,15
Synaptic adhesion-like molecules,15
Acyl chain remodelling of PC,15
Acyl chain remodelling of PE,15
COPI-independent Golgi-to-ER retrograde traffic,15
MicroRNA (miRNA) biogenesis,14
Post-transcriptional silencing by small RNAs,14
Deadenylation of mRNA,14
Transcriptional regulation by small RNAs,14
Nectin/Necl trans heterodimerization,14
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,14
Phospholipase C-mediated cascade: FGFR1,14
FGFR1c and Klotho ligand binding and activation,14
Endosomal/Vacuolar pathway,14
CS/DS degradation,14
FGFR1c ligand binding and activation,14
Negative regulation of FGFR1 signaling,14
PI-3K cascade:FGFR1,14
DAP12 signaling,14
FGFR1b ligand binding and activation,14
RHOG GTPase cycle,14
CD22 mediated BCR regulation,14
FRS-mediated FGFR1 signaling,14
ER-Phagosome pathway,14
RAC2 GTPase cycle,14
SHC-mediated cascade:FGFR1,14
FR-900098 and FR-33289 antibiotics biosynthesis,13
CMP-diacetamido-8-epilegionaminic acid biosynthesis,13
SARS-CoV-2 modulates host translation machinery,13
SARS-CoV-1 modulates host translation machinery,13
HS-GAG degradation,13
RHOA GTPase cycle,13
Regulation of Complement cascade,13
RHOD GTPase cycle,13
Downstream signaling of activated FGFR1,13
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),12
Removal of the Flap Intermediate from the C-strand,12
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,12
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),12
tunicamycin biosynthesis,12
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),12
Sema3A PAK dependent Axon repulsion,12
SHC-mediated cascade:FGFR3,12
Fc epsilon receptor (FCERI) signaling,12
FGFR3c ligand binding and activation,12
FGFR2b ligand binding and activation,12
Initial triggering of complement,12
FGFR2c ligand binding and activation,12
G alpha (12/13) signalling events,12
Nephrin family interactions,12
Signaling by ROBO receptors,12
Co-stimulation by ICOS,12
RAC1 GTPase cycle,12
Keratan sulfate biosynthesis,12
FCERI mediated MAPK activation,12
FGFR3b ligand binding and activation,12
CRMPs in Sema3A signaling,12
SHC-mediated cascade:FGFR2,12
"Phospholipase C-mediated cascade, FGFR4",12
Role of LAT2/NTAL/LAB on calcium mobilization,12
Keratan sulfate degradation,12
FRS-mediated FGFR4 signaling,12
FCERI mediated Ca+2 mobilization,12
FGFR4 ligand binding and activation,12
Tight junction interactions,12
Chondroitin sulfate biosynthesis,12
Dermatan sulfate biosynthesis,12
Acyl chain remodeling of DAG and TAG,12
Viral mRNA Translation,12
Selenocysteine synthesis,12
Response of EIF2AK4 (GCN2) to amino acid deficiency,12
Eukaryotic Translation Termination,12
Peptide chain elongation,12
Mitochondrial translation elongation,12
Mitochondrial translation termination,12
echinomycin and triostin A biosynthesis,11
thiocoraline biosynthesis,11
dapdiamides biosynthesis,11
CMP-N-acetyl-7-O-acetylneuraminate biosynthesis,11
Netrin-1 signaling,11
NCAM signaling for neurite out-growth,11
DSCAM interactions,11
Other semaphorin interactions,11
DAP12 interactions,11
Acyl chain remodeling of CL,11
Respiratory syncytial virus (RSV) attachment and entry,10
RSV-host interactions,10
DCC mediated attractive signaling,10
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,10
"Phospholipase C-mediated cascade, FGFR3",10
Signaling by SCF-KIT,10
PI-3K cascade:FGFR4,10
Aspirin ADME,10
Transcriptional and post-translational regulation of MITF-M expression and activity,10
Negative regulation of FGFR4 signaling,10
betaKlotho-mediated ligand binding,10
MHC class II antigen presentation,10
Proton-coupled monocarboxylate transport,10
FRS-mediated FGFR3 signaling,10
RHOC GTPase cycle,10
Fibronectin matrix formation,10
TRAF6 mediated NF-kB activation,10
NRAGE signals death through JNK,10
Regulation of KIT signaling,10
Hydrolysis of LPC,10
Basigin interactions,10
Signal regulatory protein family interactions,10
"Phospholipase C-mediated cascade, FGFR2",10
PI3K Cascade,10
Scavenging of heme from plasma,10
SHC-mediated cascade:FGFR4,10
FRS-mediated FGFR2 signaling,10
Processive synthesis on the C-strand of the telomere,9
Telomere C-strand (Lagging Strand) Synthesis,9
Telomere C-strand synthesis initiation,9
Polymerase switching on the C-strand of the telomere,9
HDR through Homologous Recombination (HRR),9
lincomycin A biosynthesis,9
Strand-asynchronous mitochondrial DNA replication,9
TAK1-dependent IKK and NF-kappa-B activation,9
Alpha-defensins,9
Interleukin-1 signaling,9
VEGF binds to VEGFR leading to receptor dimerization,9
CD28 dependent Vav1 pathway,9
Neurophilin interactions with VEGF and VEGFR,9
Downregulation of ERBB2 signaling,9
Non-integrin membrane-ECM interactions,9
Co-stimulation by CD28,9
RHOB GTPase cycle,9
RAC3 GTPase cycle,9
Butyrophilin (BTN) family interactions,9
Signal transduction by L1,9
CD28 dependent PI3K/Akt signaling,9
RHOF GTPase cycle,9
HS-GAG biosynthesis,9
Triglyceride catabolism,9
Acyl chain remodelling of PG,9
ADP signalling through P2Y purinoceptor 1,9
Synthesis of PA,9
Acyl chain remodelling of PS,9
phospho-PLA2 pathway,9
Acyl chain remodelling of PI,9
Arachidonate metabolism,9
rRNA modification in the nucleus and cytosol,9
CDP-D-arabitol biosynthesis,8
tRNA-uridine 2-thiolation (cytoplasmic),8
HDR through MMEJ (alt-NHEJ),8
platensimycin biosynthesis,8
CDP-D-mannitol biosynthesis,8
Regulation of TP53 Activity through Phosphorylation,8
Nuclear events stimulated by ALK signaling in cancer,8
tRNA-uridine 2-thiolation (thermophilic bacteria),8
colibactin biosynthesis,8
Myogenesis,8
Negative regulation of FGFR2 signaling,8
IL-6-type cytokine receptor ligand interactions,8
GRB2 events in ERBB2 signaling,8
Laminin interactions,8
Signaling by ERBB2,8
Signaling by PDGF,8
VEGFR2 mediated cell proliferation,8
Sema4D mediated inhibition of cell attachment and migration,8
ERBB2 Regulates Cell Motility,8
PECAM1 interactions,8
SHC1 events in ERBB2 signaling,8
SHC1 events in ERBB4 signaling,8
Axonal growth inhibition (RHOA activation),8
NTRK2 activates RAC1,8
VEGFA-VEGFR2 Pathway,8
Activated NTRK2 signals through PLCG1,8
Downregulation of ERBB2:ERBB3 signaling,8
Formation of the dystrophin-glycoprotein complex (DGC),8
Caspase activation via Dependence Receptors in the absence of ligand,8
Activated NTRK3 signals through PI3K,8
Downstream signal transduction,8
Negative regulation of FGFR3 signaling,8
RHO GTPases activate PAKs,8
Negative regulation of MET activity,8
Activated NTRK3 signals through PLCG1,8
Tie2 Signaling,8
Interleukin-38 signaling,8
FGFRL1 modulation of FGFR1 signaling,8
G alpha (q) signalling events,8
Signaling by ERBB4,8
PI-3K cascade:FGFR2,8
PI-3K cascade:FGFR3,8
PI3K events in ERBB4 signaling,8
Sema4D induced cell migration and growth-cone collapse,8
NTF3 activates NTRK3 signaling,8
Ligand-receptor interactions,8
Activated NTRK2 signals through FRS2 and FRS3,8
PI3K events in ERBB2 signaling,8
NCAM1 interactions,8
CDC42 GTPase cycle,8
anandamide biosynthesis I,7
anandamide biosynthesis II,7
MAPK6/MAPK4 signaling,7
TP53 Regulates Metabolic Genes,7
mRNA capping I,7
Translation of respiratory syncytial virus mRNAs,7
Assembly and release of respiratory syncytial virus (RSV) virions,7
Respiratory syncytial virus genome transcription,7
dZTP biosynthesis,7
"mono-trans, poly-cis decaprenyl phosphate biosynthesis",7
Maturation of hRSV A proteins,7
Respiratory syncytial virus genome replication,7
6-hydroxymethyl-dihydropterin diphosphate biosynthesis II (Methanocaldococcus),7
6-hydroxymethyl-dihydropterin diphosphate biosynthesis I,7
fosfomycin biosynthesis,7
pyrimidine deoxyribonucleotides dephosphorylation,7
6-hydroxymethyl-dihydropterin diphosphate biosynthesis III (Chlamydia),7
Interaction between L1 and Ankyrins,7
Interleukin-4 and Interleukin-13 signaling,7
Activation of NF-kappaB in B cells,7
Striated Muscle Contraction,7
O-linked glycosylation,7
CLEC7A (Dectin-1) signaling,7
CD209 (DC-SIGN) signaling,7
Crosslinking of collagen fibrils,7
L1CAM interactions,7
EPHB-mediated forward signaling,7
Interferon alpha/beta signaling,6
Binding and entry of HIV virion,6
type IV lipoteichoic acid biosynthesis (S. pneumoniae),6
nivalenol biosynthesis,6
anditomin biosynthesis,6
palmitoyl ethanolamide biosynthesis,6
stigma estolide biosynthesis,6
T-2 toxin biosynthesis,6
TRKA activation by NGF,6
"Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells",6
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,6
ARMS-mediated activation,6
Miscellaneous transport and binding events,6
EPHA-mediated growth cone collapse,6
Antigen processing: Ubiquitination & Proteasome degradation,6
Frs2-mediated activation,6
Macroautophagy,6
EPH-Ephrin signaling,6
Surfactant metabolism,6
Co-inhibition by CTLA4,6
Interleukin-12 signaling,6
EPH-ephrin mediated repulsion of cells,6
MAPK3 (ERK1) activation,6
Energy dependent regulation of mTOR by LKB1-AMPK,6
RHOJ GTPase cycle,6
Retrograde neurotrophin signalling,6
Co-inhibition by BTLA,6
Recycling pathway of L1,6
Interleukin-36 pathway,6
ERBB2 Activates PTK6 Signaling,6
Smooth Muscle Contraction,6
Advanced glycosylation endproduct receptor signaling,6
Role of ABL in ROBO-SLIT signaling,6
PI3K/AKT activation,6
Signaling by EGFR,6
MAPK1 (ERK2) activation,6
Interleukin-23 signaling,6
SDK interactions,6
Interleukin-6 signaling,6
SLIT2:ROBO1 increases RHOA activity,6
Interleukin-33 signaling,6
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",6
Netrin mediated repulsion signals,6
GRB7 events in ERBB2 signaling,6
Neurofascin interactions,6
RHOQ GTPase cycle,6
Phase 0 - rapid depolarisation,6
"phospholipid remodeling (phosphatidylethanolamine, yeast)",5
HCMV Late Events,5
HCMV Early Events,5
mRNA Splicing - Major Pathway,5
poly(ribitol phosphate) wall teichoic acid biosynthesis II (S. aureus),5
type I lipoteichoic acid biosynthesis (S. aureus),5
poly(ribitol phosphate) wall teichoic acid biosynthesis I (B. subtilis),5
cucurbitacin biosynthesis,5
2-O-acetyl-3-O-trans-coutarate biosynthesis,5
succinoglycan biosynthesis,5
Escherichia coli serotype O:49 O antigen biosynthesis,5
tropane alkaloids biosynthesis,5
cardenolide glucosides biosynthesis,5
aloesone and aloesin biosynthesis,5
rosamicin biosynthesis,5
flavonol acylglucoside biosynthesis II - isorhamnetin derivatives,5
candicidin biosynthesis,5
Translesion Synthesis by POLH,5
staphyloxanthin biosynthesis,5
shisonin biosynthesis,5
violdelphin biosynthesis,5
mycinamicin biosynthesis,5
mannosylerythritol lipids biosynthesis,5
superpathway of anthocyanin biosynthesis (from cyanidin and cyanidin 3-O-glucoside),5
pelargonidin conjugates biosynthesis,5
nystatin biosynthesis,5
mycolyl-arabinogalactan-peptidoglycan complex biosynthesis,5
colanic acid (Escherichia coli K12) biosynthesis,5
amaranthin biosynthesis,5
oleandomycin biosynthesis,5
avenacin A-1 biosynthesis,5
des-methyl avenacin A-1 biosynthesis,5
furaneol and mesifurane biosynthesis,5
anthocyanidin modification (Arabidopsis),5
Escherichia coli serotype O:104 O antigen biosynthesis,5
salvianin biosynthesis,5
aloin biosynthesis,5
carminate biosynthesis,5
lauryl-hydroxychlorobactene glucoside biosynthesis,5
"cyanidin 3,7-diglucoside polyacylation biosynthesis",5
salicortin biosynthesis,5
syringate degradation,5
aloenin biosynthesis,5
RIP-mediated NFkB activation via ZBP1,5
MET activates PTK2 signaling,5
AMPK inhibits chREBP transcriptional activation activity,5
Cell-extracellular matrix interactions,5
VxPx cargo-targeting to cilium,5
Integrin signaling,5
Molecules associated with elastic fibres,5
Hydrolysis of LPE,5
Insulin processing,5
NF-kB is activated and signals survival,5
Interleukin-27 signaling,5
PKMTs methylate histone lysines,5
GPVI-mediated activation cascade,5
Ephrin signaling,5
DEx/H-box helicases activate type I IFN and inflammatory cytokines production,5
Carnitine shuttle,5
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),5
Formation of WDR5-containing histone-modifying complexes,5
Mitochondrial Fatty Acid Beta-Oxidation,5
Mitochondrial translation initiation,5
aerobic respiration I (cytochrome c),4
coenzyme B/coenzyme M regeneration I (methanophenazine-dependent),4
Fe(II) oxidation,4
NAD(P)/NADPH interconversion,4
aerobic respiration III (alternative oxidase pathway),4
representative whole plasma DHA-derived icosanoids,4
linoleate metabolites biosynthesis,4
"phospholipid remodeling (phosphatidate, yeast)",4
"phospholipid remodeling (phosphatidylcholine, yeast)",4
protectin biosynthesis,4
di-homo-gamma-linolenate metabolites biosynthesis,4
icosapentaenoate metabolites biosynthesis,4
representative whole plasma EPA-derived icosanoids,4
plasmalogen degradation,4
docosahexaenoate metabolites biosynthesis,4
phosphatidylcholine acyl editing,4
peptido-conjugates in tissue regeneration biosynthesis,4
alpha-linolenate metabolites biosynthesis,4
maresin biosynthesis,4
Presynaptic phase of homologous DNA pairing and strand exchange,4
G2/M DNA damage checkpoint,4
Processing of DNA double-strand break ends,4
Homologous DNA Pairing and Strand Exchange,4
HDR through Single Strand Annealing (SSA),4
KSRP (KHSRP) binds and destabilizes mRNA,4
Ca2+ pathway,4
Transcriptional Regulation by VENTX,4
RNA Polymerase II Pre-transcription Events,4
Formation of RNA Pol II elongation complex,4
RNA Polymerase II Transcription Elongation,4
crocetin biosynthesis,4
lipoate biosynthesis and incorporation IV (yeast),4
streptovaricin biosynthesis,4
arachidonate biosynthesis II (bacteria),4
Mitochondrial transcription initiation,4
"icosapentaenoate biosynthesis II (6-desaturase, mammals)",4
palmitate biosynthesis I (type I fatty acid synthase),4
bryostatin biosynthesis,4
calonectrin biosynthesis,4
"3,3'-thiodipropanoate degradation",4
Escherichia coli serotype O:127 O antigen biosynthesis,4
harzianum A and trichodermin biosynthesis,4
ochratoxin A biosynthesis,4
sorgoleone biosynthesis,4
D-carnitine degradation I,4
acetylaszonalenin biosynthesis,4
ansatrienin biosynthesis,4
pederin biosynthesis,4
chaetoglobosin A biosynthesis,4
acrylate degradation I,4
saframycin A biosynthesis,4
hydroxycinnamate sugar acid ester biosynthesis,4
"docosahexaenoate biosynthesis IV (4-desaturase, mammals)",4
emodin biosynthesis,4
griseofulvin biosynthesis,4
rhizobactin 1021 biosynthesis,4
acinetoferrin biosynthesis,4
fusarin C biosynthesis,4
anthocyanidin 3-malylglucoside biosynthesis (acyl-glucose dependent),4
docosahexaenoate biosynthesis II (bacteria),4
bassianin and desmethylbassianin biosynthesis,4
"arachidonate biosynthesis I (6-desaturase, lower eukaryotes)",4
anthocyanidin acylglucoside and acylsambubioside biosynthesis,4
sch210971 and sch210972 biosynthesis,4
apicidin F biosynthesis,4
icosapentaenoate biosynthesis I (lower eukaryotes),4
6-methoxymellein biosynthesis,4
pentagalloylglucose biosynthesis,4
calystegine biosynthesis,4
dimethylsulfoniopropanoate degradation II (cleavage),4
avenanthramide biosynthesis,4
aromatic polyketides biosynthesis,4
cyanidin dimalonylglucoside biosynthesis,4
chloramphenicol biosynthesis,4
icosapentaenoate biosynthesis IV (bacteria),4
dTDP-alpha-D-ravidosamine and dTDP-4-acetyl-alpha-D-ravidosamine biosynthesis,4
naphthomycin biosynthesis,4
gamma-butyrobetaine degradation I,4
daurichromenate biosynthesis,4
fusaric acid biosynthesis,4
galloylated catechin biosynthesis,4
monolignol biosynthesis,4
equisetin biosynthesis,4
atranorin biosynthesis,4
leinamycin biosynthesis,4
5-N-acetylardeemin biosynthesis,4
L-Ndelta-acetylornithine biosynthesis,4
colchicine biosynthesis,4
phosphatidylcholine biosynthesis VII,4
lyngbyatoxin biosynthesis,4
clavulanate biosynthesis,4
tenellin biosynthesis,4
vanchrobactin biosynthesis,4
(Kdo)2-lipid A biosynthesis (P. putida),4
viridicatumtoxin biosynthesis,4
diadinoxanthin and fucoxanthin biosynthesis (diatoms),4
resveratrol biosynthesis,4
"(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis II (4-desaturase)",4
terminal olefins biosynthesis II,4
fusaridione A biosynthesis,4
mycobacterial sulfolipid biosynthesis,4
cholesterol degradation to androstenedione III (anaerobic),4
lampranthin biosynthesis,4
docosahexaenoate biosynthesis I (lower eukaryotes),4
gallotannin biosynthesis,4
"arachidonate biosynthesis IV (8-detaturase, lower eukaryotes)",4
L-carnitine degradation III,4
pyoluteorin biosynthesis,4
glutathione-mediated detoxification II,4
arginomycin biosynthesis,4
crotonate fermentation (to acetate and cyclohexane carboxylate),4
cylindrospermopsin biosynthesis,4
jadomycin biosynthesis,4
pseudomonine biosynthesis,4
flavonol acylglucoside biosynthesis I - kaempferol derivatives,4
holomycin biosynthesis,4
corallopyronin A biosynthesis,4
gentiodelphin biosynthesis,4
capsaicin biosynthesis,4
taxol biosynthesis,4
chaxamycin biosynthesis,4
dimycocerosyl triglycosyl phenolphthiocerol biosynthesis,4
avenacin A-2 biosynthesis,4
citreoisocoumarin and bikisocoumarin biosynthesis,4
flavonol acylglucoside biosynthesis III - quercetin derivatives,4
plumbagin biosynthesis,4
digitoxigenin biosynthesis,4
"arachidonate biosynthesis III (6-desaturase, mammals)",4
penicillin G and penicillin V biosynthesis,4
fumagillin biosynthesis,4
rosmarinic acid biosynthesis I,4
phaselate biosynthesis,4
yersiniabactin biosynthesis,4
blasticidin S biosynthesis,4
rifamycin B biosynthesis,4
spermidine hydroxycinnamic acid conjugates biosynthesis,4
tylosin biosynthesis,4
grayanate biosynthesis,4
caffeoylglucarate biosynthesis,4
fatty acid biosynthesis initiation (plant mitochondria),4
hydroxycinnamic acid serotonin amides biosynthesis,4
Spodoptera littoralis pheromone biosynthesis,4
glycine lipid biosynthesis,4
aspyridone A biosynthesis,4
hinokiresinol biosynthesis,4
putrebactin biosynthesis,4
"icosapentaenoate biosynthesis V (8-desaturase, lower eukaryotes)",4
baumannoferrin biosynthesis,4
"dTDP-3-acetamido-3,6-dideoxy-alpha-D-glucose biosynthesis",4
anguibactin biosynthesis,4
bacillibactin biosynthesis,4
polyacyltrehalose biosynthesis,4
stipitatate biosynthesis,4
alcaligin biosynthesis,4
ferrichrome biosynthesis,4
"aurachin A, B, C and D biosynthesis",4
phenolic malonylglucosides biosynthesis,4
aurachin RE biosynthesis,4
chlorogenic acid biosynthesis I,4
malonate degradation I (biotin-independent),4
pyrrolomycin biosynthesis,4
"vindoline, vindorosine and vinblastine biosynthesis",4
ternatin C3 biosynthesis,4
acinetobactin biosynthesis,4
capsiconiate biosynthesis,4
"(2S,3E)-2-amino-4-methoxy-but-3-enoate biosynthesis",4
alpha-cyclopiazonate biosynthesis,4
tabtoxinine-beta-lactam biosynthesis,4
Interferon gamma signaling,4
"L-ascorbate biosynthesis VII (plants, D-galacturonate pathway)",4
3-(4-sulfophenyl)butanoate degradation,4
Peptide ligand-binding receptors,4
Notch-HLH transcription pathway,4
Interleukin-20 family signaling,4
Alternative complement activation,4
O-glycosylation of TSR domain-containing proteins,4
Drug-mediated inhibition of MET activation,4
MET activates PI3K/AKT signaling,4
G alpha (i) signalling events,4
Cross-presentation of soluble exogenous antigens (endosomes),4
Potential therapeutics for SARS,4
(Kdo)2-lipid A biosynthesis (P. gingivalis),4
Interleukin receptor SHC signaling,4
Erythropoietin activates Phosphoinositide-3-kinase (PI3K),4
Interleukin-18 signaling,4
Interleukin-15 signaling,4
Extrinsic Pathway of Fibrin Clot Formation,4
HATs acetylate histones,4
pinoresinol degradation,4
Erythropoietin activates RAS,4
FLT3 signaling through SRC family kinases,4
MAP2K and MAPK activation,4
Signaling by Erythropoietin,4
indole-3-acetate activation II,4
Negative regulation of FLT3,4
Activation of C3 and C5,4
ISG15 antiviral mechanism,4
L-cysteine biosynthesis II (tRNA-dependent),4
EGFR downregulation,4
MET activates RAP1 and RAC1,4
Events associated with phagocytolytic activity of PMN cells,4
Hyaluronan uptake and degradation,4
Interleukin-2 signaling,4
MET receptor recycling,4
Glycogen synthesis,4
Extra-nuclear estrogen signaling,4
Formation of the cornified envelope,4
UCH proteinases,4
MET Receptor Activation,4
Lysosomal oligosaccharide catabolism,4
Regulated proteolysis of p75NTR,4
Thyroxine biosynthesis,4
Syndecan interactions,4
4-hydroxyacetophenone degradation,4
p130Cas linkage to MAPK signaling for integrins,4
MET activates PTPN11,4
MET activates STAT3,4
FCGR3A-mediated IL10 synthesis,4
Activation of SMO,4
Acrosome Reaction and Sperm:Oocyte Membrane Binding,4
CLEC7A/inflammasome pathway,4
MAP3K8 (TPL2)-dependent MAPK1/3 activation,4
vitamin B6 degradation II,4
deoxynivalenol biosynthesis,4
GRB2:SOS provides linkage to MAPK signaling for Integrins,4
Platelet Adhesion to exposed collagen,4
geranyl acetate biosynthesis,4
heparan sulfate biosynthesis,4
Growth hormone receptor signaling,4
Interleukin-10 signaling,4
MET interacts with TNS proteins,4
Prolactin receptor signaling,4
FLT3 Signaling,4
Neddylation,4
MET activates RAS signaling,4
"2,4-dichlorotoluene degradation",4
misacylated tRNA editing,4
phosphatidylcholine resynthesis via glycerophosphocholine,4
rutin degradation,4
FCGR3A-mediated phagocytosis,4
D-galacturonate degradation III,4
"L-ascorbate biosynthesis V (euglena, D-galacturonate pathway)",4
D-glucuronate degradation III,4
Fatty acyl-CoA biosynthesis,4
Vitamin B5 (pantothenate) metabolism,4
Mitochondrial protein degradation,3
Integration of provirus,3
APOBEC3G mediated resistance to HIV-1 infection,3
Budding and maturation of HIV virion,3
G1/S-Specific Transcription,3
Early Phase of HIV Life Cycle,3
Uncoating of the HIV Virion,3
Defective pyroptosis,3
Cytosolic iron-sulfur cluster assembly,3
tRNA splicing I,3
Pre-NOTCH Transcription and Translation,3
Autointegration results in viral DNA circles,3
Minus-strand DNA synthesis,3
Assembly Of The HIV Virion,3
Integration of viral DNA into host genomic DNA,3
Vpr-mediated nuclear import of PICs,3
Signaling by BRAF and RAF1 fusions,3
2-LTR circle formation,3
Plus-strand DNA synthesis,3
mRNA Splicing - Minor Pathway,3
Telomere Extension By Telomerase,3
SARS-CoV-2 activates/modulates innate and adaptive immune responses,3
spinosyn biosynthesis,3
sibiromycin biosynthesis,3
p-HBAD biosynthesis,3
Escherichia coli serotype O:52 O antigen biosynthesis,3
hesperitin glycoside biosynthesis,3
eupatolitin 3-O-glucoside biosynthesis,3
daphnetin modification,3
protein N-glycosylation (Haloferax volcanii),3
polymethylated quercetin glucoside biosynthesis I - quercetin series (Chrysosplenium),3
Formation of the beta-catenin:TCF transactivating complex,3
polymethylated quercetin glucoside biosynthesis II - quercetagetin series (Chrysosplenium),3
Escherichia coli serotype O:8 O antigen biosynthesis,3
mycofactocin biosynthesis,3
superpathway of scopolin and esculin biosynthesis,3
esculetin modification,3
staurosporine biosynthesis,3
Signal attenuation,3
Interleukin-21 signaling,3
IRS-related events triggered by IGF1R,3
Intrinsic Pathway of Fibrin Clot Formation,3
Acetylcholine Neurotransmitter Release Cycle,3
Glutamate Neurotransmitter Release Cycle,3
RUNX3 regulates NOTCH signaling,3
Streptococcus pneumoniae serotype 4 capsular polysaccharide biosynthesis,3
Norepinephrine Neurotransmitter Release Cycle,3
HDL assembly,3
NIK-->noncanonical NF-kB signaling,3
Defective B3GALT6 causes EDSP2 and SEMDJL1,3
SHC-related events triggered by IGF1R,3
"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",3
Golgi Associated Vesicle Biogenesis,3
SUMOylation of immune response proteins,3
Type I hemidesmosome assembly,3
PTK6 promotes HIF1A stabilization,3
Dopamine Neurotransmitter Release Cycle,3
CLEC7A (Dectin-1) induces NFAT activation,3
hispidol and hispidol 4'-O-beta-D-glucoside biosynthesis,3
GPER1 signaling,3
MDK and PTN in ALK signaling,3
Insulin receptor signalling cascade,3
Regulation of endogenous retroelements by KRAB-ZFP proteins,3
Common Pathway of Fibrin Clot Formation,3
IRS activation,3
oleandomycin activation/inactivation,3
Interleukin-1 processing,3
ROBO receptors bind AKAP5,3
Regulation of MITF-M dependent genes involved in invasion,3
EGR2 and SOX10-mediated initiation of Schwann cell myelination,3
Interleukin-9 signaling,3
RHOV GTPase cycle,3
Dectin-1 mediated noncanonical NF-kB signaling,3
Synthesis of IP3 and IP4 in the cytosol,3
Serotonin Neurotransmitter Release Cycle,3
Signaling by CSF3 (G-CSF),3
Regulation of IFNA/IFNB signaling,3
Synthesis of PIPs at the Golgi membrane,3
Signaling by Insulin receptor,3
Activation of RAC1,3
Defective EXT2 causes exostoses 2,3
Interleukin-7 signaling,3
Inactivation of CSF3 (G-CSF) signaling,3
beta-D-mannosyl phosphomycoketide biosynthesis,3
Nef Mediated CD8 Down-regulation,3
Calcineurin activates NFAT,3
Escherichia coli serotype O:149/Shigella boydii serotype O1 O antigen biosynthesis,3
podophyllotoxin glucosides metabolism,3
Synthesis of PIPs at the plasma membrane,3
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),3
Regulation of commissural axon pathfinding by SLIT and ROBO,3
RHOU GTPase cycle,3
Attachment and Entry,3
Pexophagy,3
Defective CHST6 causes MCDC1,3
Defective CHST3 causes SEDCJD,3
Amyloid fiber formation,3
Extracellular matrix organization,3
Pregnenolone biosynthesis,3
Regulation of cortical dendrite branching,3
Terminal pathway of complement,3
Constitutive Signaling by Aberrant PI3K in Cancer,3
Interleukin-2 family signaling,3
"Synthesis of IP2, IP, and Ins in the cytosol",3
Nef Mediated CD4 Down-regulation,3
Retinoid metabolism and transport,3
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),3
Interleukin-35 Signalling,3
"Defective B4GALT7 causes EDS, progeroid type",3
Defective CHSY1 causes TPBS,3
STAT3 nuclear events downstream of ALK signaling,3
"Defective CHST14 causes EDS, musculocontractural type",3
Defective ST3GAL3 causes MCT12 and EIEE15,3
Inactivation of CDC42 and RAC1,3
Mechanical load activates signaling by PIEZO1 and integrins in osteocytes,3
Vpu mediated degradation of CD4,3
Formation of the ureteric bud,3
flavonoid di-C-glucosylation,3
"Sensory perception of sweet, bitter, and umami (glutamate) taste",3
Creation of classical C3 convertase,3
Defective B3GAT3 causes JDSSDHD,3
phenylethanol glycoconjugate biosynthesis,3
Nef mediated downregulation of CD28 cell surface expression,3
CDP-diacylglycerol biosynthesis III,3
MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis,3
CDP-diacylglycerol biosynthesis I,3
acylceramide biosynthesis and processing,3
oleate biosynthesis III (cyanobacteria),3
bacterial bioluminescence,3
phosphatidate biosynthesis (yeast),3
plasmalogen biosynthesis I (aerobic),3
palmitoleate biosynthesis III (cyanobacteria),3
oleate biosynthesis II (animals and fungi),3
retinol biosynthesis,3
5-methoxybenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP,2
Regulation of NPAS4 mRNA translation,2
FGFR2 alternative splicing,2
Mitochondrial RNA degradation,2
adenosylcobalamin biosynthesis from adenosylcobinamide-GDP II,2
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,2
adenosylcobalamin biosynthesis from adenosylcobinamide-GDP I,2
Oxidative Stress Induced Senescence,2
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),2
Impaired BRCA2 binding to PALB2,2
Oncogene Induced Senescence,2
adeninyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP,2
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,2
Regulation of CDH11 mRNA translation by microRNAs,2
PIWI-interacting RNA (piRNA) biogenesis,2
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,2
benzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP,2
SUMOylation of DNA damage response and repair proteins,2
Regulation of MITF-M-dependent genes involved in apoptosis,2
Estrogen-dependent gene expression,2
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,2
M-decay: degradation of maternal mRNAs by maternally stored factors,2
5-hydroxybenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP,2
4-methylphenyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP,2
2-methyladeninyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP,2
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,2
TGFBR3 expression,2
5-methylbenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP,2
IRF3-mediated induction of type I IFN,2
Regulation of PTEN mRNA translation,2
Impaired BRCA2 binding to RAD51,2
superpathway of adenosylcobalamin salvage from cobinamide II,2
phenyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP,2
Regulation by TREX1,2
Transcriptional Regulation by MECP2,2
ATF4 activates genes in response to endoplasmic reticulum stress,2
Regulation of MECP2 expression and activity,2
Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs),2
[2Fe-2S] iron-sulfur cluster biosynthesis,2
5-methoxy-6-methylbenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP,2
Defective homologous recombination repair (HRR) due to BRCA1 loss of function,2
Regulation of RUNX1 Expression and Activity,2
petrobactin biosynthesis,2
Transcriptional activation of mitochondrial biogenesis,2
Maturation of replicase proteins,2
gentamicin biosynthesis,2
choline biosynthesis II,2
tetrahydromethanopterin biosynthesis,2
SARS-CoV-1 activates/modulates innate immune responses,2
Translation of Replicase and Assembly of the Replication Transcription Complex,2
domoic acid biosynthesis,2
gliotoxin biosynthesis,2
kainate biosynthesis,2
curacin A biosynthesis,2
Dectin-2 family,2
quercetin glucoside degradation (Allium),2
NrCAM interactions,2
lestaurtinib-resistant FLT3 mutants,2
KW2449-resistant FLT3 mutants,2
Escherichia coli serotype O:157/Salmonella enterica serotype O:30 O antigen biosynthesis,2
salidroside biosynthesis,2
tamatinib-resistant FLT3 mutants,2
fructan degradation,2
prunasin and amygdalin biosynthesis,2
superpathway of anthocyanin biosynthesis (from pelargonidin 3-O-glucoside),2
Signaling by plasma membrane FGFR1 fusions,2
Signaling by activated point mutants of FGFR1,2
kaempferol glycoside biosynthesis (Arabidopsis),2
Porphyromonas gingivalis O-LPS antigen biosynthesis,2
Activated NTRK3 signals through RAS,2
Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex,2
crenolanib-resistant FLT3 mutants,2
NTF4 activates NTRK2 (TRKB) signaling,2
sunitinib-resistant FLT3 mutants,2
xylan biosynthesis,2
Dasatinib-resistant KIT mutants,2
Sorafenib-resistant KIT mutants,2
Assembly of collagen fibrils and other multimeric structures,2
betacyanin biosynthesis,2
ponatinib-resistant FLT3 mutants,2
Signaling by FGFR1 in disease,2
megalomicin A biosynthesis,2
indole-3-acetate inactivation VIII,2
alpha-dystroglycan glycosylation,2
cytokinins 7-N-glucoside biosynthesis,2
saponin biosynthesis II,2
chalcone 2'-O-glucoside biosynthesis,2
cyanidin diglucoside biosynthesis (acyl-glucose dependent),2
rutin degradation (plants),2
paromomycin biosynthesis,2
Regorafenib-resistant KIT mutants,2
tuberonate glucoside biosynthesis,2
6'-deoxychalcone metabolism,2
Escherichia coli serotype O:177 O antigen biosynthesis,2
Signaling by FGFR2 fusions,2
Activated NOTCH1 Transmits Signal to the Nucleus,2
Interleukin-37 signaling,2
Shigella boydii serotype 6 O antigen biosynthesis,2
LDL clearance,2
maysin biosynthesis,2
geranyl beta-primeveroside biosynthesis,2
Signaling by FGFR3 in disease,2
phosphatidylinositol mannoside biosynthesis,2
Nilotinib-resistant KIT mutants,2
chitin degradation I (archaea),2
indole-3-acetate inactivation IV,2
BDNF activates NTRK2 (TRKB) signaling,2
Signaling by FGFR3 fusions in cancer,2
Imatinib-resistant KIT mutants,2
Escherichia coli serotype O:117 O antigen biosynthesis,2
luteolinidin 5-O-glucoside biosynthesis,2
luteolin triglucuronide degradation,2
galactosylcyclitol biosynthesis,2
myxol-2' fucoside biosynthesis,2
"2,4,6-trinitrotoluene degradation",2
luteolin glycosides biosynthesis,2
GP1b-IX-V activation signalling,2
brassinosteroids inactivation,2
Escherichia coli serotype O:111/Salmonella enterica serotype O:35 O antigen biosynthesis,2
gilteritinib-resistant FLT3 mutants,2
Salmonella enterica serotype O:13 O antigen biosynthesis,2
"protein N-glycosylation processing of proteins targeted for retention in cellular organelles (cis-Golgi, yeast)",2
Escherichia coli serotype O:7 O antigen biosynthesis,2
acylated cyanidin galactoside biosynthesis,2
Signaling by juxtamembrane domain KIT mutants,2
Cargo concentration in the ER,2
leucine-derived hydroxynitrile glucoside biosynthesis,2
linustatin bioactivation,2
Signaling by activated point mutants of FGFR3,2
Role of second messengers in netrin-1 signaling,2
"Interleukin-3, Interleukin-5 and GM-CSF signaling",2
aurone biosynthesis,2
Activated NTRK2 signals through CDK5,2
sphingolipid biosynthesis (plants),2
"2,2'-bis-(4-hydroxy-3-methybut-2-enyl)-beta,beta-carotene monoglucoside biosynthesis",2
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,2
PLC-gamma1 signalling,2
NOTCH1 Intracellular Domain Regulates Transcription,2
naringenin glycoside biosynthesis,2
Stimuli-sensing channels,2
CHL1 interactions,2
curcumin glucoside biosynthesis,2
"protein O-mannosylation II (mammals, core M1 and core M2)",2
Anchoring fibril formation,2
Escherichia coli serotype O:152 O antigen biosynthesis,2
Collagen chain trimerization,2
ajugose biosynthesis I (galactinol-dependent),2
Escherichia coli serotype O:15 O antigen biosynthesis,2
Collagen biosynthesis and modifying enzymes,2
Escherichia coli serotype O:9 O antigen biosynthesis,2
xanthan biosynthesis,2
Escherichia coli serotype O:128 O antigen biosynthesis,2
t(4;14) translocations of FGFR3,2
NAD salvage (plants),2
apigenin glycosides biosynthesis,2
NGF-independant TRKA activation,2
NOTCH2 Activation and Transmission of Signal to the Nucleus,2
cichoriin interconversion,2
"Salmonella enterica serotype O:6,7 O antigen biosynthesis",2
(+)-secoisolariciresinol diglucoside biosynthesis,2
Signalling to STAT3,2
Transcriptional regulation of granulopoiesis,2
monolignol glucosides biosynthesis,2
Imatinib-resistant PDGFR mutants,2
A series fagopyritols biosynthesis,2
sorafenib-resistant FLT3 mutants,2
Sphingolipid de novo biosynthesis,2
Signaling by MST1,2
Senescence-Associated Secretory Phenotype (SASP),2
Signalling to p38 via RIT and RIN,2
Escherichia coli serotype O:169 O antigen biosynthesis,2
Escherichia coli serotype O:55/Salmonella enterica serotype O:50 O antigen biosynthesis,2
Salmonella enterica serotype O:18 O antigen biosynthesis,2
Collagen degradation,2
Signaling by ERBB2 KD Mutants,2
protein O-mannosylation I (yeast),2
N-methylanthraniloyl-beta-D-glucopyranose biosynthesis,2
kaempferide triglycoside biosynthesis,2
protein N-glycosylation (Methanococcus voltae),2
quizartinib-resistant FLT3 mutants,2
human milk oligisaccharides biosynthesis,2
yeast mannan degradation,2
IFNG signaling activates MAPKs,2
RND2 GTPase cycle,2
chitin derivatives degradation,2
RND3 GTPase cycle,2
RND1 GTPase cycle,2
indole-3-acetate inactivation III,2
"C25,25 CDP-archaeol biosynthesis",2
"Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition",2
Formation of paraxial mesoderm,2
VLDL clearance,2
kaempferol diglycoside biosynthesis (pollen-specific),2
starch degradation I,2
Signaling by FGFR1 amplification mutants,2
cytokinins 9-N-glucoside biosynthesis,2
quercetin glucoside biosynthesis (Allium),2
NOTCH3 Intracellular Domain Regulates Transcription,2
STAT5 Activation,2
Defective B3GALTL causes PpS,2
PDGFR mutants bind TKIs,2
Pyruvate metabolism,2
superpathway of anthocyanin biosynthesis (from delphinidin 3-O-glucoside),2
isoorientin biosynthesis II,2
Sunitinib-resistant KIT mutants,2
Long-term potentiation,2
proanthocyanidins biosynthesis from flavanols,2
Signalling to RAS,2
teichuronic acid biosynthesis (B. subtilis 168),2
NTRK3 as a dependence receptor,2
COPI-mediated anterograde transport,2
Epithelial-Mesenchymal Transition (EMT) during gastrulation,2
Escherichia coli serotype O:56 O antigen biosynthesis,2
Signaling by FGFR2 amplification mutants,2
Sorafenib-resistant PDGFR mutants,2
Escherichia coli serotype O:107 O antigen biosynthesis,2
acetan biosynthesis,2
PCP/CE pathway,2
Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin,2
steviol glucoside biosynthesis (rebaudioside A biosynthesis),2
ajugose biosynthesis II (galactinol-independent),2
Activated NTRK2 signals through FYN,2
Regorafenib-resistant PDGFR mutants,2
lipid A-core biosynthesis (P. gingivalis),2
KIT mutants bind TKIs,2
apigeninidin 5-O-glucoside biosynthesis,2
Activated NTRK2 signals through PI3K,2
dhurrin degradation,2
MyD88:MAL(TIRAP) cascade initiated on plasma membrane,2
saponin biosynthesis III,2
indole-3-acetate inactivation VI,2
FLT3 mutants bind TKIs,2
Streptococcus pneumoniae serotype 2 capsular polysaccharide biosynthesis,2
midostaurin-resistant FLT3 mutants,2
kappa-carrageenan degradation,2
indole-3-acetate inactivation I,2
cellulose degradation II (fungi),2
peptidoglycan biosynthesis III (mycobacteria),2
Signaling by NTRK3 (TRKC),2
B series fagopyritols biosynthesis,2
protein O-glycosylation (Neisseria),2
Assembly of the 'signalling complexes',2
Regulation of IFNG signaling,2
quercetin diglycoside biosynthesis (pollen-specific),2
ulvan degradation,2
salicylate glucosides biosynthesis II,2
vitexin and derivatives biosynthesis,2
anthocyanidin sophoroside metabolism,2
salicylate glucosides biosynthesis III,2
COPII-mediated vesicle transport,2
cellulose and hemicellulose degradation (cellulolosome),2
Signaling by FLT3 ITD and TKD mutants,2
Activated NTRK2 signals through RAS,2
ginsenosides biosynthesis,2
sesaminol glucoside biosynthesis,2
Signaling by FGFR2 IIIa TM,2
xyloglucan biosynthesis,2
mitomycin biosynthesis,2
myricetin gentiobioside biosynthesis,2
semaxanib-resistant FLT3 mutants,2
Masitinib-resistant KIT mutants,2
stellariose and mediose biosynthesis,2
Escherichia coli serotype O:71/Salmonella enterica serotype O:28ac O antigen biosynthesis,2
fructan biosynthesis,2
Escherichia coli serotype O:2 O antigen biosynthesis,2
dalcochinin biosynthesis,2
stachyose degradation,2
quercetin gentiotetraside biosynthesis,2
Nef mediated downregulation of MHC class I complex cell surface expression,2
"protein N-glycosylation processing of mannoproteins (cis-Golgi, yeast)",2
Escherichia coli serotype O:50 O antigen biosynthesis,2
Salmonella enterica serotype O:39 O antigen biosynthesis,2
Signaling by ERBB2 TMD/JMD mutants,2
Signaling by extracellular domain mutants of KIT,2
kaempferol gentiobioside biosynthesis,2
Signaling by PDGFRA extracellular domain mutants,2
FGFR4 mutant receptor activation,2
baicalein metabolism,2
pexidartinib-resistant FLT3 mutants,2
benzoyl-beta-D-glucopyranose biosynthesis,2
starch degradation V,2
"(1,4)-beta-D-xylan degradation",2
Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),2
Modulation by Mtb of host immune system,2
Signaling by FGFR4 in disease,2
jasmonoyl-L-isoleucine inactivation,2
Nuclear signaling by ERBB4,2
GABA receptor activation,2
sarcinaxanthin diglucoside biosynthesis,2
Signaling by kinase domain mutants of KIT,2
rhabduscin biosynthesis,2
STAT5 activation downstream of FLT3 ITD mutants,2
microcin B17 biosynthesis,2
rose anthocyanin biosynthesis I (via cyanidin 5-O-beta-D-glucoside),2
Escherichia coli serotype O:85/Salmonella enterica serotype O:17 O antigen biosynthesis,2
"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",2
Signaling by FGFR2 in disease,2
Class B/2 (Secretin family receptors),2
poly(3-O-beta-D-glucopyranosyl-N-acetylgalactosamine 1-phosphate) wall teichoic acid biosynthesis,2
"Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",2
FLT3 signaling by CBL mutants,2
tandutinib-resistant FLT3 mutants,2
saponin biosynthesis IV,2
mammalian high-mannose N-glycan degradation,2
astaxanthin dirhamnoside biosynthesis,2
trichloroethene degradation,2
vitamin K degradation,2
cytokinin-O-glucosides biosynthesis,2
Escherichia coli serotype O:1B/Salmonella enterica serotype O:42 O antigen biosynthesis,2
starch degradation IV,2
NOTCH4 Intracellular Domain Regulates Transcription,2
High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells,2
salicylate glucosides biosynthesis IV,2
Signaling by membrane-tethered fusions of PDGFRA or PDGFRB,2
afrormosin conjugates interconversion,2
genistin gentiobioside biosynthesis,2
"Escherichia coli serotype O:77/Salmonella enterica serotype O:6,14 O antigen biosynthesis",2
daphnin interconversion,2
Escherichia coli serotype O:183/Shigella boydii serotype O:10 O antigen biosynthesis,2
Signaling by CSF1 (M-CSF) in myeloid cells,2
Salmonella enterica serotype O:54 O antigen biosynthesis,2
wogonin metabolism,2
E3 ubiquitin ligases ubiquitinate target proteins,2
polyhydroxydecanoate biosynthesis,2
isovitexin glycosides biosynthesis,2
Escherichia coli serotype O:51/Salmonella enterica serotype O:57 O antigen biosynthesis,2
NTF3 activates NTRK2 (TRKB) signaling,2
globo-series glycosphingolipids biosynthesis,2
calycosin 7-O-glucoside biosynthesis,2
Activated point mutants of FGFR2,2
quercetin glycoside biosynthesis (Arabidopsis),2
linifanib-resistant FLT3 mutants,2
Escherichia coli serotype O:21/Salmonella enterica serotype O:38 O antigen biosynthesis,2
Sunitinib-resistant PDGFR mutants,2
roquefortine C biosynthesis,2
demethylmenaquinol-8 biosynthesis II,2
demethylmenaquinol-6 biosynthesis II,2
peptidoglycan cross-bridge biosynthesis IV (Weissella viridescens),1
SUMOylation of chromatin organization proteins,1
protein SAMPylation and SAMP-mediated thiolation,1
homophytochelatin biosynthesis,1
peptidoglycan cross-bridge biosynthesis III (Enterococcus faecalis),1
"2,4-dichlorophenoxyacetate degradation",1
coniferyl alcohol 9-methyl ether biosynthesis,1
salvigenin biosynthesis,1
yatein biosynthesis II,1
plastoquinol-9 biosynthesis II,1
crotonosine biosynthesis,1
arctigenin and isoarctigenin biosynthesis,1
clorobiocin biosynthesis,1
Transcription of SARS-CoV-2 sgRNAs,1
dTDP-sibirosamine biosynthesis,1
polymethylated kaempferol biosynthesis,1
5-methoxy-6-methylbenzimidazole biosynthesis (anaerobic),1
methylthiopropanonate degradation II (demethylation),1
ginkgotoxin biosynthesis,1
3-hydroxy-4-methyl-proline biosynthesis,1
kavain biosynthesis,1
"7,8-dimethylmenaquinone biosynthesis",1
elloramycin biosynthesis,1
ascomycin biosynthesis,1
bacimethrin and bacimethrin pyrophosphate biosynthesis,1
5-methoxybenzimidazole biosynthesis (anaerobic),1
"spirilloxanthin and 2,2'-diketo-spirilloxanthin biosynthesis",1
okenone biosynthesis,1
esculetin biosynthesis,1
gibberellin biosynthesis V,1
"diacylglyceryl-N,N,N-trimethylhomoserine biosynthesis",1
bixin biosynthesis,1
autoinducer AI-2 biosynthesis I,1
methiin metabolism,1
furaquinocin biosynthesis,1
TRAF3-dependent IRF activation pathway,1
spheroidene and spheroidenone biosynthesis,1
4-chloro-2-methylphenoxyacetate degradation,1
Amaryllidacea alkaloids biosynthesis,1
polymethylated quercetin biosynthesis,1
pinitol biosynthesis II,1
snRNP Assembly,1
"gibberellin biosynthesis I (non C-3, non C-13 hydroxylation)",1
gossypol biosynthesis,1
6-methoxypodophyllotoxin biosynthesis,1
Transcription of SARS-CoV-1 sgRNAs,1
autoinducer AI-2 biosynthesis II (Vibrio),1
Replication of the SARS-CoV-2 genome,1
gibberellin biosynthesis IV (Gibberella fujikuroi),1
"5,6-dimethylbenzimidazole biosynthesis II (anaerobic)",1
gibberellin biosynthesis III (early C-13 hydroxylation),1
isoflavonoid biosynthesis II,1
tetracenomycin C biosynthesis,1
gamma-coniciene and coniine biosynthesis,1
Assembly of the SARS-CoV-2 Replication-Transcription Complex (RTC),1
"10,13-epoxy-11-methyl-octadecadienoate biosynthesis",1
coumarins biosynthesis (engineered),1
methylwyosine biosynthesis,1
Replication of the SARS-CoV-1 genome,1
rot-2'-enonate biosynthesis,1
glucosinolate biosynthesis from homomethionine,1
homogalacturonan biosynthesis,1
arsenic detoxification (mammals),1
sulfur volatiles biosynthesis,1
"Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence",1
Assembly of the SARS-CoV-1 Replication-Transcription Complex (RTC),1
shinorine biosynthesis,1
yangonin biosynthesis,1
TBC/RABGAPs,1
ergotamine biosynthesis,1
emetine biosynthesis,1
phenylpropanoids methylation (ice plant),1
nevadensin biosynthesis,1
pentalenolactone biosynthesis,1
vestitol and sativan biosynthesis,1
3-hydroxy-4-methyl-anthranilate biosynthesis I,1
polymethylated myricetin biosynthesis (tomato),1
dechlorogriseofulvin biosynthesis,1
meleagrin biosynthesis,1
gibberellin inactivation I (2beta-hydroxylation),1
UTP and CTP dephosphorylation I,1
gibberellin biosynthesis II (early C-3 hydroxylation),1
vanillin biosynthesis I,1
3-hydroxy-4-methyl-anthranilate biosynthesis II,1
7-dehydroporiferasterol biosynthesis,1
"5,6-dehydrokavain biosynthesis (engineered)",1
aucuparin biosynthesis,1
pinobanksin biosynthesis,1
apratoxin A biosynthesis,1
"1,3,5-trimethoxybenzene biosynthesis",1
L-methionine biosynthesis IV,1
Translesion synthesis by Pol kappa,1
6-gingerol biosynthesis,1
epiberberine biosynthesis,1
brassicicene C biosynthesis,1
papaverine biosynthesis,1
8-O-methylated benzoxazinoid glucoside biosynthesis,1
gliotoxin inactivation,1
glucosinolate biosynthesis from tryptophan,1
neopentalenoketolactone and pentalenate biosynthesis,1
geodin biosynthesis,1
sulfazecin biosynthesis,1
dTDP-beta-L-evernitrose biosynthesis,1
10-methylstearate biosynthesis,1
mRNA capping II,1
beta-alanine betaine biosynthesis,1
superpathway of benzoxazinoid glucosides biosynthesis,1
hectochlorin biosynthesis,1
gibberellin inactivation II (methylation),1
hopanoid biosynthesis (bacteria),1
D-cycloserine biosynthesis,1
"3,5-dimethoxytoluene biosynthesis",1
quinolinone B biosynthesis,1
ajmaline and sarpagine biosynthesis,1
neoxaline biosynthesis,1
Regulation of PLK1 Activity at G2/M Transition,1
Anchoring of the basal body to the plasma membrane,1
trehalose biosynthesis V,1
Signaling downstream of RAS mutants,1
chitin degradation II (Vibrio),1
xyloglucan degradation II (exoglucanase),1
Transcriptional activtion and repression of REL-68 target genes,1
sucrose biosynthesis II,1
Platelet Aggregation (Plug Formation),1
virginiae butanolide type gamma-butyrolactones biosynthesis,1
3-phosphoinositide degradation,1
Trehalose biosynthesis,1
"Activated IkappaB kinase (IKK) complex, Phospho IRD5:KEY dimer, phosphorylates REL in the PGN:PGRP-LC/LE receptor 'signalling complex'",1
3-phosphoinositide biosynthesis,1
IM-2 type gamma-butyrolactones biosynthesis,1
(+)-camphor biosynthesis,1
Activation of AMPK downstream of NMDARs,1
peptidoglycan biosynthesis II (staphylococci),1
starch biosynthesis,1
Erythropoietin activates STAT5,1
ceramide and sphingolipid recycling and degradation (yeast),1
peptidoglycan recycling II,1
Formation of the activated receptor complex,1
Signaling by high-kinase activity BRAF mutants,1
roseoflavin biosynthesis,1
Transcriptional regulation of white adipocyte differentiation,1
juvenile hormone III biosynthesis I,1
Formation of the activated STAT92E dimer and transport to the nucleus,1
gellan degradation,1
Apoptotic cleavage of cell adhesion proteins,1
"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",1
A-factor gamma-butyrolactone biosynthesis,1
"Degradation of NF-kappa-B inhibitor, CACT",1
Somitogenesis,1
beta-D-glucuronide and D-glucuronate degradation,1
Signaling by moderate kinase activity BRAF mutants,1
"Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1",1
1-(sn-glycero-3-phospho)-1D-myo-inositol biosynthesis,1
geraniol biosynthesis (cytosol),1
MECP2 regulates neuronal receptors and channels,1
Evasion by RSV of host interferon responses,1
Transcriptional regulation of brown and beige adipocyte differentiation by EBF2,1
Erythropoietin activates Phospholipase C gamma (PLCG),1
glycogen degradation II,1
Regulation of necroptotic cell death,1
Activation of PPARGC1A (PGC-1alpha) by phosphorylation,1
"Phosphorylated CACT, DL and DIF homodimers dissociate from the TL receptor 'signalling complex'",1
rhamnogalacturonan type I degradation II (bacteria),1
Lipophagy,1
The NLRP3 inflammasome,1
"D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis",1
protein O-[N-acetyl]-glucosylation,1
Dephosphorylation by PTP61F phosphatases,1
neolinustatin bioactivation,1
"protein O-mannosylation III (mammals, core M3)",1
lotaustralin degradation,1
Insulin signaling pathway,1
salmochelin degradation,1
glycogen biosynthesis II (from UDP-D-Glucose),1
"D-myo-inositol (1,4,5)-trisphosphate degradation",1
MPS VII - Sly syndrome,1
InlB-mediated entry of Listeria monocytogenes into host cell,1
chitin degradation III (Serratia),1
phytate degradation I,1
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,1
Regulation of MITF-M-dependent genes involved in cell cycle and proliferation,1
"Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2",1
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,1
Glycogen storage disease type IV (GBE1),1
ALK mutants bind TKIs,1
erythritol biosynthesis II,1
coumarin biosynthesis (via 2-coumarate),1
1D-myo-inositol hexakisphosphate biosynthesis II (mammalian),1
"beta-(1,4)-mannan degradation",1
pectin degradation I,1
NFkB activation mediated by RIP1 complexed with activated TLR3,1
cyclobis-(1rarr6)-alpha-nigerosyl biosynthesis,1
Defective CSF2RB causes SMDP5,1
protein ubiquitination,1
Signaling by ALK fusions and activated point mutants,1
diethylphosphate degradation,1
Regulation of NFE2L2 gene expression,1
mannosylglucosylglycerate biosynthesis I,1
2-arachidonoylglycerol biosynthesis,1
RUNX1 regulates transcription of genes involved in interleukin signaling,1
DL and DIF homodimers bind to TUB and phosphorylated PLL in the TL receptor 'signalling complex',1
1-(sn-glycero-1-phospho)-1D-myo-inositol biosynthesis,1
Defective CSF2RA causes SMDP4,1
VEGFR2 mediated vascular permeability,1
adenosylcobinamide-GDP salvage from assorted adenosylcobamides,1
AURKA Activation by TPX2,1
REL binds to DREDD in the PGN:PGRP-LC/LE receptor 'signalling complex',1
butachlor degradation,1
starch degradation II,1
RHOH GTPase cycle,1
linamarin degradation,1
NOTCH2 intracellular domain regulates transcription,1
Signaling by Leptin,1
di-myo-inositol phosphate biosynthesis,1
Constitutive Signaling by NOTCH1 PEST Domain Mutants,1
erythritol biosynthesis I,1
OAS antiviral response,1
"Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3",1
peptidoglycan biosynthesis IV (Enterococcus faecium),1
"D-myo-inositol (1,3,4)-trisphosphate biosynthesis",1
Loss of Nlp from mitotic centrosomes,1
Regulation of signaling by CBL,1
Myoclonic epilepsy of Lafora,1
glycogen biosynthesis III (from alpha-maltose 1-phosphate),1
"D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis",1
Signaling by RAF1 mutants,1
Paradoxical activation of RAF signaling by kinase inactive BRAF,1
Purinergic signaling in leishmaniasis infection,1
MPS I - Hurler syndrome,1
Translocation of SLC2A4 (GLUT4) to the plasma membrane,1
Regulation of MITF-M-dependent genes involved in pigmentation,1
(-)-camphor biosynthesis,1
starch degradation III,1
Transcriptional activtion by phosphorylated DL/DIF dimer,1
DL and DIF homodimers complexed with CACT are all phosphorylated in the TL receptor 'signalling complex',1
firefly bioluminescence,1
serinol biosynthesis,1
Loss of proteins required for interphase microtubule organization from the centrosome,1
"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",1
Recruitment of mitotic centrosome proteins and complexes,1
Expression and translocation of olfactory receptors,1
Phosphorylated REL is cleaved by and dissociates from DREDD,1
NGF-stimulated transcription,1
D-myo-inositol-5-phosphate metabolism,1
IkBA variant leads to EDA-ID,1
RAF activation,1
Negative regulation of MAPK pathway,1
toyocamycin biosynthesis,1
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,1
Recruitment of NuMA to mitotic centrosomes,1
ergosterol biosynthesis II,1
fatty acid biosynthesis initiation (type I),1
naphthalene degradation (anaerobic),1
indolmycin biosynthesis,1
oleate biosynthesis I (plants),1
(-)-microperfuranone biosynthesis,1
"(1'S,5'S)-averufin biosynthesis",1
stearate biosynthesis IV,1
fumiquinazoline D biosynthesis,1
rhizocticin A and B biosynthesis,1
gondoate biosynthesis (anaerobic),1
"caffeine degradation V (bacteria, via trimethylurate)",1
hypoglycin biosynthesis,1
palmitoleate biosynthesis I (from (5Z)-dodec-5-enoate),1
(5Z)-dodecenoate biosynthesis II,1
choline biosynthesis I,1
xanthohumol biosynthesis,1
nocardicin A biosynthesis,1
p-cumate degradation to 2-hydroxypentadienoate,1
acyl-[acyl-carrier protein] thioesterase pathway,1
achromobactin biosynthesis,1
palmitate biosynthesis III,1
alliin metabolism,1
"2,3-dihydroxybenzoate degradation",1
lovastatin biosynthesis,1
palmitate biosynthesis II (type II fatty acid synthase),1
microcin C biosynthesis,1
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,1
ubiquinol-8 biosynthesis (late decarboxylation),1
UDP-yelosamine biosynthesis,1
"methymycin, neomethymycin and novamethymycin biosynthesis",1
dimycocerosyl phthiocerol biosynthesis,1
brominated pyrroles biosynthesis,1
vibriobactin biosynthesis,1
ubiquinol-10 biosynthesis (late decarboxylation),1
2-allylmalonyl-CoA biosynthesis,1
fatty acid biosynthesis initiation (type II),1
asperlicin E biosynthesis,1
8-amino-7-oxononanoate biosynthesis IV,1
L-ascorbate degradation V,1
even iso-branched-chain fatty acid biosynthesis,1
ubiquinol-9 biosynthesis (late decarboxylation),1
phloridzin biosynthesis,1
XBP1(S) activates chaperone genes,1
ferrichrome A biosynthesis,1
erythromycin D biosynthesis,1
UDP-D-apiose biosynthesis (from UDP-D-glucuronate),1
cis-vaccenate biosynthesis,1
ibotenate and muscimol biosynthesis,1
pyoverdine I biosynthesis,1
"5,5'-dehydrodivanillate degradation",1
"narbomycin, pikromycin and novapikromycin biosynthesis",1
oleate biosynthesis IV (anaerobic),1
flavonoid biosynthesis (in equisetum),1
ubiquinol-7 biosynthesis (late decarboxylation),1
palmitoleate biosynthesis II (plants and bacteria),1
echinocandin B biosynthesis,1
anteiso-branched-chain fatty acid biosynthesis,1
ubiquinol-6 biosynthesis from 4-aminobenzoate (yeast),1
"octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast)",1
ChREBP activates metabolic gene expression,1
methyl ketone biosynthesis (engineered),1
saliniketal A biosynthesis,1
8-amino-7-oxononanoate biosynthesis I,1
aureobasidin A biosynthesis,1
petroselinate biosynthesis,1
sterigmatocystin biosynthesis,1
naringenin biosynthesis (engineered),1
superpathway of mycolate biosynthesis,1
seleno-amino acid detoxification and volatilization II,1
peramine biosynthesis,1
picolinate degradation,1
"L-tryptophan degradation XI (mammalian, via kynurenine)",1
Activation of gene expression by SREBF (SREBP),1
stearate biosynthesis II (bacteria and plants),1
dimethylsulfoniopropanoate biosynthesis II (Spartina),1
odd iso-branched-chain fatty acid biosynthesis,1
Dimycocersyl phthiocerol biosynthesis,1
benzene degradation III (anaerobic),1
seleno-amino acid biosynthesis (plants),1
hyperxanthone E biosynthesis,1
menaquinol-4 biosynthesis II,1
tridecaprenyl diphosphate biosynthesis,1
aflatrem biosynthesis,1
all trans undecaprenyl diphosphate biosynthesis,1
stephacidin A biosynthesis,1
penigequinolone biosynthesis,1
alizarin biosynthesis,1
3-amino-5-hydroxybenzoate biosynthesis,1
carrageenan biosynthesis,1
neurosporaxanthin biosynthesis,1
wighteone and luteone biosynthesis,1
rhizobitoxine biosynthesis,1
kievitone biosynthesis,1
rubber biosynthesis,1
paxilline and diprenylpaxilline biosynthesis,1
aspoquinolone biosynthesis,1
dodecaprenyl diphosphate biosynthesis,1
diazepinomicin biosynthesis,1
lolitrem B biosynthesis,1
